Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nanotechnology standards move forward

This article was originally published in Clinica

Executive Summary

December 15 is the deadline by which interested parties must respond to the first four new work item proposals that have been put forward by the European standards committee on nanotechnology, CEN/TC 352. The committee will next meet on April 24-25 2007. This committee covers nanotechnology in general, and not just nanomedicine. It is chaired by Dr Trudy Phelps, chair of the CEN Advisory Board for Healthcare Standards (AHBS).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT053611

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel